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RESEARCH BRIEFING NO. 6 
Key Informant Interviews: 
End of Life Care for People with Alcohol and Drug Problems 
“We need to be developing 
services [that] provide the 
same level of care around end 
of life for people with drug 
and alcohol problems [as 
they] would if they were dying 
from anything else.... 
everybody deserves as good a 
death as we can help them to 
have.” 
 
(Frontline Health and Social Care 
Practitioner) 
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Key findings 
 
1. Current definitions and ways of understanding palliative care, and addiction 
recovery, do not easily apply to people with current or previous problematic 
substance use and end of life conditions.   
2. The client group is not a straightforward one – there are often complex and 
multiple physical, psychological and social morbidities which impact upon 
their identification, engagement with services and the delivery of care.   
3. There are significant issues with the fragmentation and inflexibility of service 
providers which affect the care they receive.  However, it is possible to 
identify the characteristics of a good joined-up and compassionate approach 
to care.   
4. Substance use receives little attention in national or local policy around 
palliative and end of life care; and palliative and end of life care receives 
little attention in national or local policy around substance use.   
5. Prescribing for pain and/or symptom management for people with substance 
use and end of life conditions is a complex area but good practice is 
achievable.   
6. Family members of people with substance problems at the end of their lives 
can be viewed negatively and receive little support both at the end of their 
relative’s life and after their death.   
 
Background 
 
There are growing public health concerns about the morbidity and mortality of 
people with alcohol and/or drug problems. Among these are concerns about the 
care they receive, the current climate in which substance use treatment 
services are commissioned and delivered, and inequalities in substance use 
treatment, palliative care (PC) and end of life (EOL) care. The experiences and 
needs of families of people with substance use problems, including those who 
have been bereaved by substance use, have also been highlighted. Overall, 
however, there is a paucity of research about EOL care for people with 
substance use problems and their families, and a lack of policy and practice 
attention about the specific experiences and needs of these cohorts of patients 
and families and of the professionals who have contact with them. There has 
also been a lack of research which has investigated professional views on caring 
for this group of patients and their families.  
 
The aim of the Key Informant (KI) interviews was to inform the rest of the 
project by investigating existing models of practice or care pathways for 
supporting adults with substance problems needing EOL care and the 
families/carers of these people.   
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Methodology 
 
Semi-structured interviews were conducted with a purposive sample of 
interviewees identified in a variety of ways. These included people identified 
through the literature, people known to the research team, or suggestions 
made by the interviewees. The interview topic guide covered five broad areas: 
   
i. key challenges and opportunities people faced when someone had both 
substance use and end of life care needs;  
ii. identifying, where possible, current models of practice at individual and 
organisational levels;  
iii. the relevance of the policy context at regional and national levels;  
iv. the organisations people work with or access;  
v. and awareness of projects already working in this area. 
 
Interviews were audio recorded and transcribed. They were analysed using 
template analysis and thematic networks supported by the Nvivo software 
package.   
Findings 
 
A total of 17 interviews were completed with 20 people – 16 professionals, one 
person with experience and three family members (the family members talked 
about the same relative who had died). The professionals were a diverse group 
with expertise in palliative and EOL care, and substance use. They included 
frontline health and social care professionals (HSCPs) working at a local level, 
senior health and social care professionals working at a local level, those 
working nationally in policy or commissioning, and a small number of others.   
 
Qualitative analysis identified seven broad themes in two overarching areas: 
‘the wider landscape’, and ‘engaging and responding’.   
 
The Wider Landscape 
 
Definitions and perceptions 
Interviewees debated the application of the common definitions of palliative 
care, EOL care, and recovery from substance use, with many viewing them as 
not applicable to those with substance use problems at the end of life. 
Interviewees also recognised that it remains difficult to talk about death and 
dying, and that the stigma often associated with substance use can add to such 
challenges. Further, interviewees thought that views of what constitutes a ‘good 
death’ may also need to be reconsidered, and that societal attitudes to 
substance use can affect access to care.   
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“… palliative care with people with substance use issues needs a 
bit of a re-brand...it’s a huge bombshell to drop on somebody with 
no plan of action going forward.” (Frontline HSCP) 
 
“…the majority of [substance use treatment] services really are 
focused on recovery – so if you've got somebody with liver 
disease that realistically isn't looking very likely to recover, all of 
the services are directed at detox and at rehab, whereas there’s 
certain people that’s not going to happen or it’s unlikely to 
happen.” (Other Professional) 
 
Size and nature of the problem 
Interviewees recognised the increasing prevalence of mortality in people with 
substance use problems, and of the particular problems seen in recent years 
with the growing use of drugs like novel psychoactive substances.  Interviewees 
highlighted a number of common characteristics of this group, including their 
younger age, increasing problems in older people often because of co-existing 
health conditions, and of the multiple physical health, mental health, and social 
issues which many patients present with.  Overall, this is a group of people who 
present many challenges for health and social care professionals.   
 
“I think probably a bigger issue is knowing that the need is a 
great deal more out there than we ever see and how we reach 
that is an issue.” (Policy & Commissioning Professionals) 
 
“[they] end up living in dire circumstances with no support to 
actually look after them at their end of life.... they don’t even 
have anybody to go to the shop to buy a pint of milk...it’s very 
dirty, they haven't got anything, they haven't even got the basics, 
some people haven't got a bed.” (Frontline HSCP) 
 
Commissioning and delivery 
Interviewees had a generally negative view of the current commissioning 
arrangements for both substance use treatment services, and palliative and EOL 
care services, and of the impact this has on delivering the highest quality care 
to people with substance use and EOL concerns.  Interviewees further 
suggested that substance use policy does not sufficiently address EOL care, and 
vice versa, and that this population needs to be addressed in both areas of 
policy.  Interviewees outlined a number of key, overlapping, challenges that 
they think are greatly affecting national and local commissioning and practice.  
Namely: fragmentation; inflexibility; being stretched in terms of both capacity 
and financial resources; agendas that are too mainstream and cancer focused; 
the need for dedicated roles, services and champions; the need for integrated 
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and/or specialist commissioning; debates as to whether care should be 
centralised or community focused; a lack of local direction and guidance; and 
workforce development.   
 
“…multi morbidities seem to be becoming more common so it’s 
not only physical health but mental health and the need to be 
able to treat all of those as people approach the end of life and 
the difficulties doing that, when services do seem to be 
increasingly fragmented.” (Policy & Commissioning Professionals) 
 
“It’s sad because you're under-resourced for what you do and 
the end of life should be the best and we now have to go with 
good enough.” (Frontline HSCP) 
 
Engaging and Responding 
 
Engaging clients 
Interviewees talked about numerous challenges in the timely identification of 
EOL in people with substance use problems, and the barriers which many 
people can experience in accessing services. A common challenge was the 
unpredictable nature of some conditions like alcohol liver disease and how this 
affects identification at the right time that someone is coming towards the end 
of life.  Related to this, interviewees, particularly those working in the 
substance use sector, discussed how hard it can be to ask questions that might 
lead to improved identification.  Engagement is greatly influenced by stigma, 
which can have many forms, practical access to services, and whether services 
support people who want to continue to use substances while they are receiving 
EOL care.  Interviewees made suggestions about what can facilitate 
engagement of a group who are largely invisible or forgotten, including building 
trusted relationships with people, in order to make asking difficult questions and 
having conversations possible. 
 
“[the] fluctuating nature of the symptoms and the illness [of 
liver disease] ...it’s identifying at what point should palliative 
care get involved.” (Other Professional) 
 
“I think they are hugely disserviced...they present frequently, 
they’re not listened to, they’re diagnosed late.” (Senior HSCP) 
 
“I think drugs and alcohol users are an easy target to blame, 
they don’t get much sympathy and no-one seems to look at why 
people are taking drugs and alcohol....and it’s just hard to shift 
that out of anyone.” (Frontline HSCP) 
6 
 
 
 
  
Managing and developing care responses 
Interviewees talked about some of the key issues which influenced the delivery 
of care, particularly a person-centred approach, joined-up working, and pain 
and symptom management.  The key components of a person-centred 
approach identified by interviewees were relationships, holistic care, accessible 
and flexible care, communication, and the provision of personal care.  In 
relation to joined up working interviewees highlighted the importance of 
treatment and palliation in parallel; tackling fragmentation; reciprocal expertise 
and knowledge; communication; and clarifying who is responsible for care.  
Pain and symptom management was one of the more prevalent themes in the 
data and interviewees discussed the challenges of managing pain and 
symptoms alongside substance use; differing approaches to the problem 
between professionals; talking about pain and symptom management; 
education and training; issues related to families and peers; and working 
together.  Interviewees also talked about their experiences of care in key 
settings including primary care, drug and alcohol treatment, hospitals, hostels 
and hospices. 
 
“it’s a person-centred approach that palliative care, end of life 
care, needs to take, it’s so where are they now and what can we, 
how can we improve where you are or your end of life 
experience, how can we make that what you want it to be? 
(Frontline HSCP) 
 
“if just one of us of each can come together and keep 
talking...we’re going to make an improvement...it’s got to be 
collaborative, no doubt in my mind” (Frontline HSCP)  
 
“people that traditionally are taking drugs, have got a higher 
tolerance and they’re terrified when they come to end of life and 
being in pain and not being given enough drugs, I just reassure 
them that the team will take it into account and there won’t be a 
limit on your pain relief and I think that stops people stockpiling 
as well, if you give guarantees that your pain relief will be the 
main focus, if you need higher amounts of drugs, you’ll get 
them. A lot of people just want reassurance that their end of life 
will be as comfortable as it can be” (Frontline HSCP)  
 
(Not) talking about substance use or death and dying 
Interviewees described three areas where conversations could be difficult to 
have with people with EOL and substance use issues.  Namely, talking about 
substance use itself; giving and receiving an EOL diagnosis; and talking about 
death and dying, including palliative and EOL care. Interviewees discussed the 
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importance of choice around substance use, rather than professionals 
demanding abstinence. They often felt that ‘wake up calls’ often do not work, 
and highlighted the importance of a proactive and person-centred approach to 
discussing end of life with someone.   
 
“I’ve found an interesting approach that worked for me...you 
don’t ask them to stop drinking, you sort of take alcohol away 
and say ‘...so now because this addiction is part of your illness, 
we need to start thinking about how we’re going to plan the 
end of your life’...you take away the, ‘If you don’t stop drinking, 
you’ll die’...and change the focus to ‘drinking is part of your 
pathology, we need to deal with that in the same way as we 
need to deal with your liver chemistry’ .“ (Senior HSCP) 
 
Families and networks 
Interviewees talked about the experiences of families, the perceptions of 
families and professionals towards each other, issues regarding death 
certificates and the official cause of death, and support for families both before 
and after death. Overall, families were more likely to be viewed negatively, and 
there was limited recognition and discussion of the needs of families both 
before and after the death of their loved one.     
 
“I just think families is going to be...a big issue for our client 
group as they approach the end of life.” (Policy & 
Commissioning Professionals) 
 
“Why did they always have a stern, cold exterior to everything 
that they said? Whenever you spoke to them, it was so abrupt 
and there was no feeling, there was nothing there...I know 
sympathy and empathy are two very different things but they 
should at least empathise with the family.” (Family) 
Summary 
 
Overall, the interviews identified similar issues at both national and local levels, 
and across substance use and palliative and EOL care.  At times it makes for 
bleak reading, with interviewees talking about professions and systems under 
enormous multiple pressures and which, along with stigma and prejudice, mean 
that this group of patients (and often also their families) is unlikely to receive 
the right, and best quality, care at the right time and delivered in the right way.  
However, the interviews also contain optimism and hope for how the needs of 
this group of people should be best met. Characteristics of good care, and 
pockets of good practice, were highlighted, all of which could be harnessed to 
raise awareness, improve identification, encourage more good practice 
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(including around supporting continued substance use, and pain/symptom 
management) and tackle stigma. The developing care response cannot be ‘one 
size fits all’, but must cater for a client group that has a very wide-ranging 
demographic profile and that will most likely present with multiple, and often 
chronic and longstanding, physical, psychological and social problems.  The 
response must also be holistic and include addressing the needs of families and 
close others.     
 
Overall, interviewees were critical of policy and commissioning and identified a 
number of challenges and barriers which impede the provision of timely, holistic 
and adequate care. These reflect wider dilemmas and challenges which are 
facing both substance misuse treatment and palliative and EOL care. Given the 
multiple and complex needs of many people with substance use and EOL 
concerns, there is a greater need for multi-disciplinary and joined up care and 
care pathways and for national and local policy and commissioning practice to 
reflect this. There is also a need for resources and guidance to help 
professionals in a range of settings which identify, and engage with, the dual 
issues. Also needed is a programme of workforce development that can support 
people to feel comfortable and confident to talk about these issues with 
patients, families and colleagues. 
Conclusion 
 
The KI interviews have given a unique, and hitherto unknown, insight in to the 
experiences and challenges of working with adults with substance use problems 
and a life limiting condition.  Interviewees identified numerous individual, 
organisational, and strategic challenges to identifying this group and delivering 
timely, efficient, joined up and compassionate care.  There is much to do to 
better meet the needs of a sizeable, but largely neglected group of adults and 
their families – these interviews offered constructive suggestions for how care 
can be improved.   
 
Implications 
 
Implications for Practice and Policy 
1. There is a need for greater reciprocity in national and local policy, where 
palliative and EOL policy considers the needs of those with substance use 
concerns, and substance use policy considers the needs of those with 
palliative and EOL care needs.  
2. Practice and policy, at both national and local levels, needs to be fully holistic 
to better meet the needs of families, either alongside their loved one and/or 
in their own right.  
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3. There is a need for guidance, and improved inter-service collaboration, to 
support the earlier identification of, and engagement with, a complex 
patient/client group who are often reluctant to engage with services.  
4. There is a need for guidance on issues surrounding prescribing, and how 
they can be addressed while not compromising the care of those who wish to 
continue drinking or taking drugs. 
5. How can policy cater for the differing needs of sub-groups of people with 
substance use and EOL concerns. 
 
Implications for Research 
1. How can current definitions and ways of understanding palliative care, and 
addiction recovery, be better applied to people with substance use and EOL 
concerns? 
2. What might the core components be of an improved national and local policy 
response to this patient/client group? 
3. How can we better understand the complexities of prescribing for pain 
and/or symptom management, including for those who wish to continue 
drinking or using drugs? What are the components and facilitators of good 
practice and in this area? 
4. Given the diversity of the KI sample, there is potentially a need for similar 
research to further explore the key issues which have arisen and how they 
might apply to different professional groups across England/the UK.  
5. How does care need to differ to meet the needs of sub-groups of people with 
substance use and EOL concerns – for example, by gender, age, ethnicity, 
nature of substance use.  
 
Further Information 
 
❖ Our programme of research on End of Life Care for People with Alcohol and 
Other Drug Problems has six strands. This Briefing summarises Strand 6, 
which aimed to investigate existing models of practice and care for 
supporting people with substance problems needing end of life care and their 
families/carers.   
❖ This Briefing was authored by Lorna Templeton and Sarah Galvani. 
❖ We thank the Big Lottery Fund for funding the wider project of which this 
Briefing is a part. We also thank all the interviewees who gave their time so 
generously to speak with us.   
❖ Ethical approval for the KI interview study was obtained from Manchester 
Metropolitan University, and all interviewees gave informed consent.   
❖ For further information please see/contact Professor Sarah Galvani, 
s.galvani@mmu.ac.uk. 
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